We found that CD inhibited CTSL protein levels in a dose dependent manner in the lung cancer cell line A549, triple-negative breast cancer cell line MDA-MB-231, and prostate cancer cell line PC3, respectively (Figure 8A-C). This evidence concerns the gene CTSL and prostate carcinoma.